Using mathematical modeling to estimate time-independent cancer chemotherapy efficacy parameters.

One of the primary cancer treatment modalities is chemotherapy. Unfortunately, traditional anti-cancer drugs are often not selective and cause damage to healthy cells, leading to serious side effects for patients. For this reason more targeted therapeutics and drug delivery methods are being developed. The effectiveness of new treatments is initially determined via in vitro cell viability assays, which determine the  of the drug. However, these assays are known to result in estimates of  that depend on the measurement time, possibly resulting in over- or under-estimation of the . Here, we test the possibility of using cell growth curves and fitting of mathematical models to determine the  as well as the maximum efficacy of a drug ( ). We measured cell growth of MCF-7 and HeLa cells in the presence of different concentrations of doxorubicin and fit the data with a logistic growth model that incorporates the effect of the drug. This method leads to measurement time-independent estimates of  and , but we find that  is not identifiable. Further refinement of this methodology is needed to produce uniquely identifiable parameter estimates.